Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas

Journal of Neurosurgery

Volumn 86, Issue 4, 1997, Pages 603-609

  Black, Keith L ^a   Cloughesy, Tim ^b   Huang, Sung Cheng ^b   Gobin, Y Pierre ^b   Zhou, Yun ^b   Grous, John ^b   Nelson, Gillian ^b   Farahani, Keyvan ^b   Hoh, Carl K ^b   Phelps, Michael ^b  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

blood brain barrier; bradykinin; glioma; permeability; positron emission tomography; RMP 7

Indexed keywords

ANTINEOPLASTIC AGENT; BRADYKININ DERIVATIVE; CARBOPLATIN; GALLIUM EDETATE GA 68; LOBRADIMIL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; GLIOBLASTOMA; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR VOLUME;

EID: 0030888267     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.86.4.0603     Document Type: Article

References (28)

1. Aoki S, Terada H, Kosuda S, et al: Supraophthalamic chemotherapy with long tapered catheter: distribution evaluated with intraarterial and intravenous Tc-99m HMPAO. Radiology 188:347-350, 1993
2. Black KL: Biochemical opening of the blood-brain barrier. Adv Drug Deliv Rev 15:37-52, 1995
3. DeVita VT Jr: Principles of chemotherapy, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 4. Philadelphia: JB Lippincott, 1993, pp 283-284
4. Elliott PJ, Hayward NJ, Dean RL, et al: Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7. Immunopharmacology 33: 205-208, 1996
5. Elliott PJ, Hayward NJ, Huff MR, et al: Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. Exp Neurol 141:214-224, 1996
6. Fenstermacher JD, Cowles AL: Theoretic limitations of intracarotid infusion in brain tumor chemotherapy. Cancer Treat Rep 61:519-526, 1977
7. Groothuis DR, Fischer JM, Lapin G, et al: Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol 41:164-185, 1982
8. Groothuis DR, Warkne PC, Molnar P, et al: Effect of hyperosmotic blood-brain barrier disruption on transcapillary transport in canine brain tumors. J Neurosurg 72:441-449, 1990
9. 68Ga EDTA and positron computed tomograph. J Cereb Blood Flow Metab 4:507-515, 1985
10. 68Ga EDTA by positron emission tomography in human brain tumors. Acta Neurol Scand 72:104, 1985
11. Inamura T, Black KL: Bradykinin selectively opens blood-tumor barrier in experimental tumors. J Cereb Blood Flow Metab 14:862-870, 1994
12. Inamura T, Nomura T, Bartus RT, et al: Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. J Neurosurg 81:752-758, 1994
13. Inoue T, Fukui M, Nishio S, et al: Hyperosmotic blood-brain barrier disruption in the brains of rats with an intracerebrally transplanted RG-C6 tumor. J Neurosurg 66:256-263, 1987
14. Kumagai AK, Eisenberg JB, Pardridge WM: Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem 262:15214-15219, 1987
15. Lin KP, Huang SC, Baxter LR, et al: A general technique for interstudy registration of multifunction and multimodality images. IEEE Trans Nucl Sci 41:2850-2855, 1994
16. Matsukado K, Inamura T, Nakano S, et al: Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39:125-134, 1996
17. Matsukado K, Nakano S, Bartus RT, et al: Steroids decrease uptake of carboplatin in rat gliomas - uptake improved by intracarotid infusion of bradykinin analog, RMP-7. J Neurol Oncol (In press)
18. Nakano S, Matsukado K, Black KL: Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7. Neurol Res (In press)
19. Nakano S, Matsukado K, Black KL: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56:4027-4031, 1996
20. Neuwelt EA, Barnett PA, Bigner DD, et al: Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci USA 79:4420-4423, 1982
21. Neuwelt EA, Barnett PA, McCormick CI, et al: Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neurosurgery 17:419-423, 1985
22. Neuwelt EA, Hill SA, Frenkel EP: Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery 15:362-366, 1984
23. Neuwelt EA, Rapoport SI: Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc 43:214-219, 1984
24. Nomura T, Inamura T, Black KL: Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res 659:62-66, 1994
25. Pardridge WM, Kumagai AK, Eisenberg JB: Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier. Biochem Biophys Res Commun 146: 307-313, 1987
26. Rainov NG, Zimmer C, Chase M, et al: Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther 6:1543-1552, 1995
27. Tomiwa K, Hazama F, Mikawa H: Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier. Neuropathol Appl Neurobiol 9:345-354, 1983
28. Yu DC, Huang SC, Lin KP, et al: Movement correction of FDOPA PET dynamic studies using frame-to-frame registration. Biomed Eng Appl Basis Commun 6:660-671, 1994